TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular Carcinoma.

Timil H Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.